Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Orlando, Florida

CNS trials open to children and teens in Orlando, FL

11 CNS studies open to children and teens are recruiting participants at sites in Orlando as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Orlando at a glance

  • 11 studies are recruiting at a site in Orlando.
  • By phase: Phase 3 (8), Phase 4 (1), No phase (1), Observational (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (9), university, hospital or other (2).
  • By research area: ADHD (3), Depression (3), Migraine (3), Schizophrenia (2).
  • Most recent update to one of these records: November 12, 2026.

ADHD studies recruiting in Orlando

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT07717892 · updated
  3. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Study sites
    APG Research LLC · Clinical Neuroscience Solutions, Inc.
    Registry record
    NCT04781140 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Orlando, FL on ClinicalTrials.gov.

Depression studies recruiting in Orlando

  1. Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

    • Phase 3
    • Ages 10 to 17
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    APG Research LLC
    Registry record
    NCT06372964 · updated
  2. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Study site
    Nemours Foundation
    Registry record
    NCT07048574 · updated
  3. Adapting Single Sessions Interventions for Type 1 Diabetes

    • No phase
    • Ages 12 to 17
    • All sexes
    Sponsor
    Nemours Children's Health System
    Study site
    Nemours Children's Hospital - FL
    Registry record
    NCT06752369 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Orlando, FL on ClinicalTrials.gov.

Migraine studies recruiting in Orlando

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Clinical Associates of Orlando, LLC
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Clinical Associates of Orlando, LLC
    Registry record
    NCT04743141 · updated
  3. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Clinical Associates of Orlando, LLC /ID# 272619
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Orlando, FL on ClinicalTrials.gov.

Schizophrenia studies recruiting in Orlando

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Apg Research, Llc
    Registry record
    NCT07288567 · updated
  2. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Apg Research, Llc
    Registry record
    NCT07424404 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Orlando, FL on ClinicalTrials.gov.

Ask about studies near Orlando

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call